查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1613162

避孕藥具市場：依產品、年齡層、藥物類別、處方形式、分佈、給藥途徑 - 2025-2030 年全球預測

Contraceptive Pills Market by Product (Combination Pill, Continuous/Extended Pill, Progesterone Pill), Age Group (15-24, 25-34, 35-44), Drug Class, Mode of Prescription, Distribution, Route of Administration - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年避孕藥具市場價值為195.3億美元，預計到2024年將達到207.6億美元，複合年成長率為6.46%，到2030年將達到302.7億美元。

避孕藥市場的定義是透過抑制排卵的荷爾蒙製劑來預防懷孕。口服避孕藥有多種類型，包括雌激素和黃體素複方口服避孕藥和純黃體素藥丸，它們主要針對育齡婦女。避孕藥具的需求源於人們對計劃生育意識的提高、對有效預防懷孕方法的需求以及賦予婦女做出生育選擇的權力。這些藥物不僅可用於避孕，還可用於治療月經失調、痤瘡和子宮內膜異位症，從而將最終用途範圍擴大到不同的人。教育水準的提高、醫療保健機會的增加以及政府對避孕措施支持的增加對市場成長產生了重大影響。低劑量藥物的最新進展和長週期藥物的推出為市場擴張提供了潛在的機會。為了利用這些機會，公司應專注於提高負擔能力、擴大分銷管道並透過教育宣傳活動提高意識。然而，副作用風險、道德和宗教反對以及監管限制等挑戰可能會阻礙市場擴張。此外，由於文化偏見和缺乏意識，一些地區的市場滲透率有限。該領域的創新已經成熟，可以開發非荷爾蒙藥丸、個人化醫療方法以及用於改善和追蹤藥物依從性的數位健康解決方案。這些創新以及與醫療保健提供者的策略夥伴關係關係可以推動業務成長。該市場呈現出分散但動態的特點，並具有透過併購進行整合的潛力。總體而言，響應不斷變化的需求和觀念、投資研發並專注於個人化體驗對於在這個競爭激烈但前景光明的市場中獲得成長至關重要。

主要市場統計
基準年[2023] 195.3億美元
預測年份 [2024] 207.6億美元
預測年份 [2030] 302.7億美元
複合年成長率（%） 6.46%

市場動態：揭示快速發展的避孕市場的關鍵市場洞察

供需的動態交互作用正在改變避孕藥具市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 增加避孕藥具的使用以防止意外懷孕並提高計劃生育意識
    • 性行為感染傳染病（STD）盛行率上升
    • 政府鼓勵避孕措施的支持措施
  • 市場限制因素
    • 因避孕藥具和不良健康影響而發生產品召回
  • 市場機會
    • 避孕藥配方和包裝的進展
    • 透過線上管道提供避孕藥具
  • 市場挑戰
    • 有關藥丸使用和產品行銷問題的安全和社會問題

波特五力：駕馭避孕市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解避孕藥市場的外部影響

外部宏觀環境因素對避孕藥具市場的表現動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解避孕藥具市場的競爭格局

對避孕藥市場的詳細市場佔有率分析可以對供應商的業績進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣避孕藥具市場供應商績效評估

FPNV定位矩陣是評估避孕藥具市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和推薦的避孕藥市場，以規劃成功之路

避孕藥市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 增加使用避孕藥來防止意外懷孕並提高計劃生育意識
      • 性行為感染傳染病（STD）盛行率增加
      • 政府支持措施促進避孕藥具的使用
    • 抑制因素
      • 避孕產品召回與不良健康影響的發生
    • 機會
      • 避孕藥配方和包裝的不斷進步
      • 透過線上管道提供避孕藥具
    • 任務
      • 有關錠劑使用和產品行銷問題的安全和社會問題
  • 市場區隔分析
    • 產品：廣泛的適用性和額外的健康益處增加了組合藥物的採用
    • 給藥途徑：口服避孕藥的廣泛接受性、可用性和成本效益
    • 年齡層：15至24歲年齡層的避孕藥使用率較高。
    • 配送：避孕藥具線上配送管道的演變
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 避孕藥市場：依產品

  • 組合藥丸
  • 延續/延長藥丸
  • 黃體酮丸

第7章 避孕藥市場：依年齡層別

  • 15-24
  • 25-34
  • 35-44
  • 45歲以上

第8章以藥物類別分類的避孕藥市場

  • 品牌藥品
  • 學名藥

第9章以處方方式分類的避孕藥市場

  • 貼片機上 (OTC)
  • 根據處方箋

第10章 避孕藥具市場經銷商

  • 離線
    • 診所和醫院
    • 藥局
    • 公共衛生機構
  • 線上

第11章 避孕藥市場：依給藥途徑

  • 口服
  • 陰道

第12章美洲避孕市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第13章亞太避孕市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第14章 歐洲、中東和非洲避孕市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第15章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Perrigo 在美國推出首款非處方每日避孕藥，旨在擴大生殖保健服務的可近性和可負擔性。
    • 英國已開始試驗無激素男性避孕藥 YCT-529，目標是在 2020 年獲得監管部門核准並進入市場。 2024年
    • Richter 和 Misra 簽署複方口服避孕藥 Ester 和 Donesta 的 API 生產和供應協議
    • FDA核准首個非處方箋口服避孕藥
    • Gedeon Richter 宣布推出口服避孕藥 Droberis
  • 戰略分析和建議

公司名單

  • AbbVie Inc.
  • Afaxys Pharma, LLC
  • Amneal Pharmaceuticals, Inc.
  • Apotex Inc.
  • Aurobindo Pharma Limited
  • Bayer AG
  • Bionpharma Inc.
  • Cipla Limited
  • Combe Incorporated
  • Gedeon Richter PLC
  • Glenmark Pharmaceuticals Limited
  • Johnson & Johnson Services, Inc.
  • Julie Product Inc.
  • Lupin Limited
  • Mankind Pharma Ltd.
  • Mayne Pharma Group Limited
  • Merck & Co., Inc.
  • Northstar Rx LLC
  • Perrigo Company plc
  • Pfizer Inc.
  • Piramal Enterprises Ltd.
  • Sun Pharmaceutical Industries Limited
  • Syzygy Healthcare Solutions, LLC
  • Teva Pharmaceuticals
  • Viatris Inc.
  • Xiromed, LLC
Product Code: MRR-A579C4315A23

The Contraceptive Pills Market was valued at USD 19.53 billion in 2023, expected to reach USD 20.76 billion in 2024, and is projected to grow at a CAGR of 6.46%, to USD 30.27 billion by 2030.

The contraceptive pills market is defined by its role in preventing pregnancy through hormonal formulations that inhibit ovulation. It encompasses various types, including combined oral contraceptives (estrogen and progestin) and progestin-only pills, catering primarily to women in reproductive age groups. The necessity of contraceptive pills stems from the increasing awareness of family planning, the need for effective pregnancy prevention methods, and the empowerment of women in making reproductive choices. These pills find applications not only in contraception but also in managing menstrual disorders, acne, and endometriosis, extending their end-use scope across diverse demographics. Market growth is heavily influenced by rising educational levels, increasing access to healthcare, and growing governmental support for birth control measures. Recent advancements in lower dosage pills and the introduction of extended-cycle pills present potential opportunities for market expansion. To tap into these opportunities, companies should focus on enhancing affordability, expanding distribution channels, and raising awareness through education campaigns. However, challenges such as the perceived risk of side effects, ethical and religious opposition, and regulatory restrictions could impede market expansion. Additionally, market penetration is limited in some regions due to cultural biases and lack of awareness. Innovations in the field are ripe in the areas of developing non-hormonal pills, personalized medicine approaches, and digital health solutions for better medication adherence and tracking. These innovations, alongside strategic partnerships with healthcare providers, can drive business growth. The market exhibits a dynamic, albeit fragmented nature, indicating potential consolidation through mergers and acquisitions. Overall, staying attuned to evolving needs and perceptions, investing in R&D, and focusing on personalized experiences will be crucial for capturing growth in this competitive yet promising market.

KEY MARKET STATISTICS
Base Year [2023] USD 19.53 billion
Estimated Year [2024] USD 20.76 billion
Forecast Year [2030] USD 30.27 billion
CAGR (%) 6.46%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Contraceptive Pills Market

The Contraceptive Pills Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing use of contraceptive pills to prevent unintended pregnancies and rising awareness about family planning
    • Growing prevalence of sexually transmitted diseases (STDs)
    • Supportive government initiatives to encourage use of contraceptive pills
  • Market Restraints
    • Incidences of product recalls & adverse health impacts of contraceptive pills
  • Market Opportunities
    • Ongoing advancements in contraceptive pill formulations and packaging
    • Availability of contraceptive pills through online channels
  • Market Challenges
    • Safety and social concerns regarding pill usage and issues with product marketing

Porter's Five Forces: A Strategic Tool for Navigating the Contraceptive Pills Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Contraceptive Pills Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Contraceptive Pills Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Contraceptive Pills Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Contraceptive Pills Market

A detailed market share analysis in the Contraceptive Pills Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Contraceptive Pills Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Contraceptive Pills Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Contraceptive Pills Market

A strategic analysis of the Contraceptive Pills Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Contraceptive Pills Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Afaxys Pharma, LLC, Amneal Pharmaceuticals, Inc., Apotex Inc., Aurobindo Pharma Limited, Bayer AG, Bionpharma Inc., Cipla Limited, Combe Incorporated, Gedeon Richter PLC, Glenmark Pharmaceuticals Limited, Johnson & Johnson Services, Inc., Julie Product Inc., Lupin Limited, Mankind Pharma Ltd., Mayne Pharma Group Limited, Merck & Co., Inc., Northstar Rx LLC, Perrigo Company plc, Pfizer Inc., Piramal Enterprises Ltd., Sun Pharmaceutical Industries Limited, Syzygy Healthcare Solutions, LLC, Teva Pharmaceuticals, Viatris Inc., and Xiromed, LLC.

Market Segmentation & Coverage

This research report categorizes the Contraceptive Pills Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Combination Pill, Continuous/Extended Pill, and Progesterone Pill.
  • Based on Age Group, market is studied across 15-24, 25-34, 35-44, and 45 and Above.
  • Based on Drug Class, market is studied across Branded Drugs and Generic Drugs.
  • Based on Mode of Prescription, market is studied across Over-the-Mounter (OTC) and Prescription-Based.
  • Based on Distribution, market is studied across Offline and Online. The Offline is further studied across Clinics and Hospitals, Pharmacies, and Public Health Organizations.
  • Based on Route of Administration, market is studied across Oral and Viginal.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing use of contraceptive pills to prevent unintended pregnancies and rising awareness about family planning
      • 5.1.1.2. Growing prevalence of sexually transmitted diseases (STDs)
      • 5.1.1.3. Supportive government initiatives to encourage use of contraceptive pills
    • 5.1.2. Restraints
      • 5.1.2.1. Incidences of product recalls & adverse health impacts of contraceptive pills
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing advancements in contraceptive pill formulations and packaging
      • 5.1.3.2. Availability of contraceptive pills through online channels
    • 5.1.4. Challenges
      • 5.1.4.1. Safety and social concerns regarding pill usage and issues with product marketing
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Emerging adoption of combination pills owing to their broad applicability and additional health benefits
    • 5.2.2. Route of Administration: Widespread acceptance, ease of access, and cost-effectiveness of oral contraceptives
    • 5.2.3. Age Group: High usage of contraceptive pills in the age group 15 to 24
    • 5.2.4. Distribution: Evolving online distribution channels for contraceptive pills
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Contraceptive Pills Market, by Product

  • 6.1. Introduction
  • 6.2. Combination Pill
  • 6.3. Continuous/Extended Pill
  • 6.4. Progesterone Pill

7. Contraceptive Pills Market, by Age Group

  • 7.1. Introduction
  • 7.2. 15-24
  • 7.3. 25-34
  • 7.4. 35-44
  • 7.5. 45 and Above

8. Contraceptive Pills Market, by Drug Class

  • 8.1. Introduction
  • 8.2. Branded Drugs
  • 8.3. Generic Drugs

9. Contraceptive Pills Market, by Mode of Prescription

  • 9.1. Introduction
  • 9.2. Over-the-Mounter (OTC)
  • 9.3. Prescription-Based

10. Contraceptive Pills Market, by Distribution

  • 10.1. Introduction
  • 10.2. Offline
    • 10.2.1. Clinics and Hospitals
    • 10.2.2. Pharmacies
    • 10.2.3. Public Health Organizations
  • 10.3. Online

11. Contraceptive Pills Market, by Route of Administration

  • 11.1. Introduction
  • 11.2. Oral
  • 11.3. Viginal

12. Americas Contraceptive Pills Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific Contraceptive Pills Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. Singapore
  • 13.10. South Korea
  • 13.11. Taiwan
  • 13.12. Thailand
  • 13.13. Vietnam

14. Europe, Middle East & Africa Contraceptive Pills Market

  • 14.1. Introduction
  • 14.2. Denmark
  • 14.3. Egypt
  • 14.4. Finland
  • 14.5. France
  • 14.6. Germany
  • 14.7. Israel
  • 14.8. Italy
  • 14.9. Netherlands
  • 14.10. Nigeria
  • 14.11. Norway
  • 14.12. Poland
  • 14.13. Qatar
  • 14.14. Russia
  • 14.15. Saudi Arabia
  • 14.16. South Africa
  • 14.17. Spain
  • 14.18. Sweden
  • 14.19. Switzerland
  • 14.20. Turkey
  • 14.21. United Arab Emirates
  • 14.22. United Kingdom

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2023
  • 15.2. FPNV Positioning Matrix, 2023
  • 15.3. Competitive Scenario Analysis
    • 15.3.1. Perrigo launched the First OTC daily birth control pill in the U.S., aiming to expand reproductive health access and affordability.
    • 15.3.2. UK launched trial for hormone-free male birth control YCT-529 aiming for regulatory approval and market entry by 2024
    • 15.3.3. Richter and Mithra sign supply agreement for production of API for combined oral contraceptive Estelle and Donesta
    • 15.3.4. FDA approves first nonprescription daily oral contraceptive
    • 15.3.5. Gedeon Richter announces availability of oral contraception Drovelis
  • 15.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. Afaxys Pharma, LLC
  • 3. Amneal Pharmaceuticals, Inc.
  • 4. Apotex Inc.
  • 5. Aurobindo Pharma Limited
  • 6. Bayer AG
  • 7. Bionpharma Inc.
  • 8. Cipla Limited
  • 9. Combe Incorporated
  • 10. Gedeon Richter PLC
  • 11. Glenmark Pharmaceuticals Limited
  • 12. Johnson & Johnson Services, Inc.
  • 13. Julie Product Inc.
  • 14. Lupin Limited
  • 15. Mankind Pharma Ltd.
  • 16. Mayne Pharma Group Limited
  • 17. Merck & Co., Inc.
  • 18. Northstar Rx LLC
  • 19. Perrigo Company plc
  • 20. Pfizer Inc.
  • 21. Piramal Enterprises Ltd.
  • 22. Sun Pharmaceutical Industries Limited
  • 23. Syzygy Healthcare Solutions, LLC
  • 24. Teva Pharmaceuticals
  • 25. Viatris Inc.
  • 26. Xiromed, LLC

LIST OF FIGURES

  • FIGURE 1. CONTRACEPTIVE PILLS MARKET RESEARCH PROCESS
  • FIGURE 2. CONTRACEPTIVE PILLS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 17. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 21. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 26. CONTRACEPTIVE PILLS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 27. CONTRACEPTIVE PILLS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CONTRACEPTIVE PILLS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CONTRACEPTIVE PILLS MARKET DYNAMICS
  • TABLE 7. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINATION PILL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY CONTINUOUS/EXTENDED PILL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY PROGESTERONE PILL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY 15-24, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY 25-34, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY 35-44, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY 45 AND ABOVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY BRANDED DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY GENERIC DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY OVER-THE-MOUNTER (OTC), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION-BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY CLINICS AND HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY PUBLIC HEALTH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY VIGINAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 84. AUSTRALIA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. AUSTRALIA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 86. AUSTRALIA CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 88. AUSTRALIA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 90. AUSTRALIA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 91. CHINA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. CHINA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 93. CHINA CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 94. CHINA CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 95. CHINA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 96. CHINA CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 97. CHINA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 98. INDIA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. INDIA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 100. INDIA CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 101. INDIA CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 102. INDIA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 103. INDIA CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 104. INDIA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 105. INDONESIA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. INDONESIA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 107. INDONESIA CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 108. INDONESIA CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 109. INDONESIA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 110. INDONESIA CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 111. INDONESIA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 112. JAPAN CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. JAPAN CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 114. JAPAN CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 115. JAPAN CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 116. JAPAN CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 117. JAPAN CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 118. JAPAN CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 119. MALAYSIA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. MALAYSIA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 121. MALAYSIA CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 122. MALAYSIA CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 123. MALAYSIA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 124. MALAYSIA CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 125. MALAYSIA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 126. PHILIPPINES CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. PHILIPPINES CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 128. PHILIPPINES CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 129. PHILIPPINES CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 130. PHILIPPINES CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 131. PHILIPPINES CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 132. PHILIPPINES CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 133. SINGAPORE CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. SINGAPORE CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 135. SINGAPORE CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 136. SINGAPORE CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 137. SINGAPORE CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 138. SINGAPORE CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 139. SINGAPORE CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 140. SOUTH KOREA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. SOUTH KOREA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 142. SOUTH KOREA CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 143. SOUTH KOREA CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 144. SOUTH KOREA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 145. SOUTH KOREA CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 146. SOUTH KOREA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 147. TAIWAN CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. TAIWAN CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 149. TAIWAN CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 150. TAIWAN CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 151. TAIWAN CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 152. TAIWAN CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 153. TAIWAN CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 154. THAILAND CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. THAILAND CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 156. THAILAND CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 157. THAILAND CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 158. THAILAND CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 159. THAILAND CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 160. THAILAND CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 161. VIETNAM CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. VIETNAM CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 163. VIETNAM CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 164. VIETNAM CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 165. VIETNAM CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 166. VIETNAM CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 167. VIETNAM CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 176. DENMARK CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 177. DENMARK CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 178. DENMARK CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 179. DENMARK CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 180. DENMARK CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 181. DENMARK CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 182. DENMARK CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 183. EGYPT CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 184. EGYPT CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 185. EGYPT CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 186. EGYPT CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 187. EGYPT CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 188. EGYPT CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 189. EGYPT CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 190. FINLAND CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 191. FINLAND CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 192. FINLAND CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 193. FINLAND CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 194. FINLAND CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 195. FINLAND CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 196. FINLAND CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 197. FRANCE CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 198. FRANCE CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 199. FRANCE CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 200. FRANCE CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 201. FRANCE CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 202. FRANCE CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 203. FRANCE CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 204. GERMANY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 205. GERMANY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 206. GERMANY CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 207. GERMANY CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 208. GERMANY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 209. GERMANY CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 210. GERMANY CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 211. ISRAEL CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 212. ISRAEL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 213. ISRAEL CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 214. ISRAEL CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 215. ISRAEL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 216. ISRAEL CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 217. ISRAEL CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 218. ITALY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 219. ITALY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 220. ITALY CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 221. ITALY CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 222. ITALY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 223. ITALY CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 224. ITALY CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 225. NETHERLANDS CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 226. NETHERLANDS CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 227. NETHERLANDS CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 228. NETHERLANDS CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 229. NETHERLANDS CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 230. NETHERLANDS CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 231. NETHERLANDS CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 232. NIGERIA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 233. NIGERIA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 234. NIGERIA CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 235. NIGERIA CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 236. NIGERIA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 237. NIGERIA CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 238. NIGERIA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 239. NORWAY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 240. NORWAY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 241. NORWAY CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 242. NORWAY CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 243. NORWAY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 244. NORWAY CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 245. NORWAY CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 246. POLAND CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 247. POLAND CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 248. POLAND CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 249. POLAND CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 250. POLAND CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 251. POLAND CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 252. POLAND CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 253. QATAR CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 254. QATAR CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 255. QATAR CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 256. QATAR CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 257. QATAR CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 258. QATAR CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 259. QATAR CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 260. RUSSIA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 261. RUSSIA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 262. RUSSIA CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 263. RUSSIA CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 264. RUSSIA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 265. RUSSIA CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 266. RUSSIA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 267. SAUDI ARABIA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 268. SAUDI ARABIA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 269. SAUDI ARABIA CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 270. SAUDI ARABIA CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 271. SAUDI ARABIA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 272. SAUDI ARABIA CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 273. SAUDI ARABIA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 274. SOUTH AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 275. SOUTH AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 276. SOUTH AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 277. SOUTH AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 278. SOUTH AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 279. SOUTH AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 280. SOUTH AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 281. SPAIN CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 282. SPAIN CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 283. SPAIN CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 284. SPAIN CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 285. SPAIN CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 286. SPAIN CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 287. SPAIN CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 288. SWEDEN CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 289. SWEDEN CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 290. SWEDEN CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 291. SWEDEN CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 292. SWEDEN CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 293. SWEDEN CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 294. SWEDEN CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 295. SWITZERLAND CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 296. SWITZERLAND CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 297. SWITZERLAND CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 298. SWITZERLAND CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 299. SWITZERLAND CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 300. SWITZERLAND CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 301. SWITZERLAND CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 302. TURKEY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 303. TURKEY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 304. TURKEY CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 305. TURKEY CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 306. TURKEY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 307. TURKEY CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 308. TURKEY CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 309. UNITED ARAB EMIRATES CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 310. UNITED ARAB EMIRATES CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 311. UNITED ARAB EMIRATES CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 312. UNITED ARAB EMIRATES CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 313. UNITED ARAB EMIRATES CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 314. UNITED ARAB EMIRATES CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 315. UNITED ARAB EMIRATES CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 316. UNITED KINGDOM CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 317. UNITED KINGDOM CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 318. UNITED KINGDOM CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 319. UNITED KINGDOM CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 320. UNITED KINGDOM CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 321. UNITED KINGDOM CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 322. UNITED KINGDOM CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 323. CONTRACEPTIVE PILLS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 324. CONTRACEPTIVE PILLS MARKET, FPNV POSITIONING MATRIX, 2023